TASE

Enlight to Supply Renewable Energy to Applied Materials Israel

Retrieved on: 
Tuesday, September 26, 2023

TEL AVIV, Israel, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”, NASDAQ: ENLT, TASE: ENLT.TA), is pleased to announce that Applied Materials Israel, a division of the leading global microchip producer Applied Materials, has entered into a 15-year corporate power purchase agreement (“PPA”) for the supply of renewable energy to its Israeli operations.

Key Points: 
  • TEL AVIV, Israel, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”, NASDAQ: ENLT, TASE: ENLT.TA), is pleased to announce that Applied Materials Israel, a division of the leading global microchip producer Applied Materials, has entered into a 15-year corporate power purchase agreement (“PPA”) for the supply of renewable energy to its Israeli operations.
  • Sourcing power from Enlight will enable Applied Materials Israel to gain traction on its ESG targets and meet a global commitment to use energy from exclusively renewable sources by 2030.
  • Gilad Yaavetz, CEO of Enlight Renewable Energy: "We are proud to provide clean electricity to Applied Materials, helping them make practical moves to net zero emissions status.
  • I anticipate that demand for renewable energy in Israel will continue to grow as other firms join this trend."

Above Food Corp. to Acquire AI-based Genomic Assets, Intellectual Property and Trait Development Technology Licensing Rights from NRGene

Retrieved on: 
Tuesday, September 26, 2023

NRGene will receive a combination of cash and stock-based consideration, as well as royalties from commercialization of specific projects.

Key Points: 
  • NRGene will receive a combination of cash and stock-based consideration, as well as royalties from commercialization of specific projects.
  • NRGene's unique AI genomic technology has already demonstrated its effectiveness in over 300 projects spanning various key crops.
  • This technology is intended to facilitate efficient trait mapping and introgression of desirable traits into elite crops.
  • By joining forces, we believe we can pave the way towards a worldwide impact on global agricultural productivity and food security".

Pomerantz Law Firm Announces Extended Lead Plaintiff Motion Deadline of October 16, 2023 in the Securities Lawsuit Pending Against Hub Cyber Security Ltd. f/k/a Hub Cyber Security (Israel) Ltd. and Certain Officers and Directors – HUBC; HUBCZ; HUBCW; RNER

Retrieved on: 
Monday, September 25, 2023

The caption for the action is: Green v. Hub Cyber Security Ltd. et al., Case No.

Key Points: 
  • The caption for the action is: Green v. Hub Cyber Security Ltd. et al., Case No.
  • Plaintiff pursues claims against Defendants under the Securities Act of 1933 (“Securities Act”) and the Securities Exchange Act of 1934 (“Exchange Act”).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Foresight Partners with One of the World's Largest Electric Vehicle Manufacturers

Retrieved on: 
Thursday, September 21, 2023

Ness Ziona, Israel, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, announced today the signing of a multi-phase cooperation agreement with a leading global electric vehicle (EV) Chinese original equipment manufacturer (OEM), specializing in EVs, rechargeable batteries and related products.

Key Points: 
  • Upon successful completion of the POC project, the parties intend to negotiate a definitive commercial agreement for the joint development, integration and commercialization of Foresight’s technology into the OEM’s automotive vision systems.
  • Furthermore, the OEM will introduce Foresight’s technology to its subsidiaries as well as customers and partners, presenting Foresight as a business partner and facilitating relationships between Foresight and the OEM’s partners.
  • A senior executive at the Chinese OEM stated, “we are constantly looking for cutting-edge and competitive technologies to retain our leadership.
  • We look forward to teaming up with Foresight to enhance our 3D perception vision systems.

BrainsWay Broadens Access to Deep TMS™ for U.S. Military Service Members Through Expanded Partnership with Katie’s Way Plus

Retrieved on: 
Wednesday, September 20, 2023

“This is yet another demonstration of our strategic focus on larger enterprise customers across the U.S.,” said Eric Hirt, VP U.S.

Key Points: 
  • “This is yet another demonstration of our strategic focus on larger enterprise customers across the U.S.,” said Eric Hirt, VP U.S.
  • September is Suicide Prevention Month, which helps raise awareness to the fact that 22 U.S. military veterans take their lives each dayi.
  • BrainsWay Deep TMS is delivered via a unique treatment coil housed in a cushioned, patient and provider-friendly helmet.
  • The patient is awake, alert, and engaged during the treatment session, and each session only takes less than 30 minutes from start to finish.

Enlight Renewable Energy Releases ESG Report

Retrieved on: 
Monday, September 18, 2023

TEL AVIV, Israel, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”, NASDAQ: ENLT, TASE: ENLT.TA), a leading global renewable energy platform, today announced the release of its 2021-2022 Environmental, Social, and Governance (ESG) report.

Key Points: 
  • TEL AVIV, Israel, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (“Enlight”, NASDAQ: ENLT, TASE: ENLT.TA), a leading global renewable energy platform, today announced the release of its 2021-2022 Environmental, Social, and Governance (ESG) report.
  • The report provides an update on Enlight’s ESG policies, initiatives, and performance.
  • “Our goal at Enlight is to accelerate the global transition to renewable energy through the development of wind, solar and energy storage projects that are moving the world closer to Net Zero.
  • A copy of the ESG report is available on the Enlight website.

Camtek to Acquire FormFactor's FRT Metrology Business

Retrieved on: 
Monday, September 18, 2023

MIGDAL HAEMEK, Israel and LIVERMORE, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), together with FormFactor, Inc. (NASDAQ: FORM), are pleased to announce that they have entered into an agreement for the acquisition by Camtek of FormFactor, Inc.’s FRT Metrology (“FRT”) business for $100 million in cash, subject to customary purchase price adjustments.

Key Points: 
  • MIGDAL HAEMEK, Israel and LIVERMORE, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), together with FormFactor, Inc. (NASDAQ: FORM), are pleased to announce that they have entered into an agreement for the acquisition by Camtek of FormFactor, Inc.’s FRT Metrology (“FRT”) business for $100 million in cash, subject to customary purchase price adjustments.
  • FRT, headquartered in Bergisch Gladbach, Germany, is a leading supplier of high-precision metrology solutions for the Advanced Packaging and Silicon Carbide markets.
  • Camtek is a market leader of inspection and 3D metrology in the semiconductor industry.
  • “We welcome FRT and its employees to the Camtek family,” said Mr. Rafi Amit, Camtek’s CEO.

Lineage to Present at Cantor Fitzgerald 2023 Global Healthcare Conference on September 27, 2023

Retrieved on: 
Tuesday, September 19, 2023

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that Brian M. Culley, Lineage’s Chief Executive Officer, will present at the Cantor Fitzgerald 2023 Global Healthcare Conference , in a fireside chat hosted by Kristen Kluska, Managing Director, Biotechnology Equity Research, Cantor Fitzgerald & Co., on September 27th, 2023 at 9:10am ET.

Key Points: 
  • Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that Brian M. Culley, Lineage’s Chief Executive Officer, will present at the Cantor Fitzgerald 2023 Global Healthcare Conference , in a fireside chat hosted by Kristen Kluska, Managing Director, Biotechnology Equity Research, Cantor Fitzgerald & Co., on September 27th, 2023 at 9:10am ET.
  • The Cantor Fitzgerald 2023 Global Healthcare Conference is being held at the InterContinental New York Barclay Hotel.
  • Interested parties can register to view a replay of the presentation on the Events and Presentations section of Lineage’s website.
  • Additional videos are available on the Media page of the Lineage website.

Industry Leader Kenny Lau joins Perion as Chief Product Officer of its Advanced Advertiser Solutions

Retrieved on: 
Tuesday, September 19, 2023

Perion Network Ltd. (NASDAQ and TASE: PERI), a global technology company whose synergistic solutions serve all major digital advertising channels - including search, social, display, and video/CTV – announced today the appointment of Kenny Lau as Chief Product Officer of Perion’s Advertiser Solutions.

Key Points: 
  • Perion Network Ltd. (NASDAQ and TASE: PERI), a global technology company whose synergistic solutions serve all major digital advertising channels - including search, social, display, and video/CTV – announced today the appointment of Kenny Lau as Chief Product Officer of Perion’s Advertiser Solutions.
  • Through his experience in multiple domains of AdTech and large-scale platform development, Lau will expand Perion’s technology moat and ability to drive high-growth, high-margin, high-ROI solutions.
  • In his most recent role as Vice President of Product of Advertiser Solutions at PubMatic, he led a global product development team of over 100 engineers and product managers.
  • “Perion has demonstrated its ability to develop and successfully introduce innovative solutions that consistently outperform the industry,” said Tal Jacobson, Perion’s CEO.

Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company

Retrieved on: 
Thursday, September 21, 2023

NEW YORK, Sept. 21, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE:ORMP) today announced that on September 21, 2023, Oramed and Scilex Holding Company ("Scilex") entered into a Securities Purchase Agreement pursuant to which Scilex issued a Senior Secured Promissory Note (the "Note") to Oramed.

Key Points: 
  • NEW YORK, Sept. 21, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE:ORMP) today announced that on September 21, 2023, Oramed and Scilex Holding Company ("Scilex") entered into a Securities Purchase Agreement pursuant to which Scilex issued a Senior Secured Promissory Note (the "Note") to Oramed.
  • The Note is the culmination of Scilex's assumption of Sorrento Therapeutics Inc.'s ("Sorrento") approximately $100 million senior secured Debtor In Possession ("DIP") term loan facility with Oramed.
  • Oramed previously announced the execution of term sheets relating to the Note on September 13, 2023.
  • "We believe that this Senior Secured Note, along with the warrant package, is a favorable outcome to Oramed while also supporting Scilex in executing on its growth opportunities."